METROPOLITAN LIFE INSURANCE CO/NY - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 148 filers reported holding VIKING THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$61,472
-27.8%
5,553
+5.7%
0.00%
-25.0%
Q2 2023$85,167
+496.8%
5,254
+10.4%
0.00%
+300.0%
Q1 2022$14,271
-79.7%
4,757
-68.9%
0.00%0.0%
Q4 2021$70,375
-38.0%
15,299
-15.4%
0.00%
-50.0%
Q3 2021$113,536
+98.3%
18,079
+89.1%
0.00%
+100.0%
Q2 2021$57,258
-55.7%
9,559
-53.3%
0.00%
-50.0%
Q1 2021$129,340
+152.6%
20,449
+124.8%
0.00%
+100.0%
Q4 2020$51,205
-38.3%
9,095
-36.3%
0.00%0.0%
Q3 2020$83,040
-46.9%
14,268
-34.2%
0.00%
-66.7%
Q2 2020$156,291
+53.5%
21,677
-0.4%
0.00%
+50.0%
Q1 2020$101,823
-38.5%
21,757
+5.4%
0.00%
-33.3%
Q4 2019$165,605
+13.8%
20,649
-2.4%
0.00%
+50.0%
Q3 2019$145,553
-17.1%
21,1560.0%0.00%
-33.3%
Q2 2019$175,595
-12.2%
21,156
+5.1%
0.00%
-25.0%
Q1 2019$200,072
+19.3%
20,128
-8.2%
0.00%
+33.3%
Q4 2018$167,703
-37.2%
21,922
+43.1%
0.00%
-40.0%
Q3 2018$266,927
-99.8%
15,3230.0%0.01%
+150.0%
Q2 2018$145,415,00015,3230.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders